In a 48-year-old obese man with type 2 diabetes mellitus, hypertension, and chronic kidney disease who presents with septic shock, refractory hypotension after a 1‑liter crystalloid bolus, tachycardia, hypoxemia, a soft third heart sound, bilateral rales, mild cardiomegaly on chest radiograph, leukocytosis, and a serum lactate of 2.0 mmol/L, which bedside test should be performed now: mixed venous oxygen saturation, pulse pressure variation, or point‑of‑care cardiac ultrasonography?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Point-of-Care Cardiac Ultrasonography

Perform point-of-care cardiac ultrasonography now to guide further resuscitation in this patient with septic shock and persistent hypotension despite initial fluid resuscitation. 1

Rationale for Cardiac Ultrasonography

This patient presents with septic shock complicated by clinical signs of cardiac dysfunction (S3 gallop, bilateral rales, cardiomegaly) and persistent hypotension after 1 liter of crystalloid. The 2025 Society of Critical Care Medicine guidelines specifically recommend critical care ultrasonography (CCUS) for hemodynamic assessment in septic shock, particularly when volume responsiveness is in question 1.

Key clinical indicators favoring ultrasound in this case:

  • Cardiac dysfunction suspected: The S3 gallop and bilateral rales suggest possible septic cardiomyopathy or fluid overload
  • Persistent shock after initial resuscitation: Blood pressure remains 92/65 mmHg despite 1L bolus and norepinephrine
  • Multiple comorbidities: Obesity, diabetes, hypertension, and chronic kidney disease increase risk of cardiac complications
  • Diagnostic uncertainty: The clinical picture could represent distributive shock, cardiogenic shock, or mixed shock states

Evidence Supporting This Approach

The 2025 SCCM guidelines demonstrate that CCUS in septic shock may reduce mortality (RR 0.86,95% CI 0.72-1.03) and significantly reduces fluid administration in the first 24 hours (mean difference -0.7L) 1. More importantly, CCUS reduces time to correct diagnosis by 1.23 hours and time to correct treatment by 20.67 hours 1.

The 2017 Surviving Sepsis Campaign guidelines emphasize that echocardiography "enables a more detailed assessment of the causes of hemodynamic issues" and recommend further hemodynamic assessment when clinical examination doesn't lead to a clear diagnosis 2. Static measures like CVP can no longer be justified for guiding fluid resuscitation 2.

Why Not the Other Options

Mixed venous oxygen saturation was part of the older EGDT protocol that has been abandoned following three large multicenter trials (PROCESS, ARISE, PROMISE) showing no mortality benefit 2. While it provides information about oxygen delivery-consumption balance, it doesn't address the immediate diagnostic question of whether this patient has cardiac dysfunction limiting further fluid resuscitation.

Pulse pressure variation has reasonable diagnostic accuracy for fluid responsiveness (sensitivity 0.72, specificity 0.91) 2, but has critical limitations in this patient:

  • Requires mechanical ventilation with adequate tidal volumes
  • Less reliable in spontaneously breathing patients
  • Doesn't identify the underlying cause of shock (distributive vs. cardiogenic vs. mixed)
  • Won't reveal if cardiac dysfunction is preventing effective resuscitation

Clinical Application

Ultrasound will immediately answer:

  • Left ventricular systolic function (septic cardiomyopathy?)
  • Right ventricular function (pulmonary embolism, right heart failure?)
  • Volume status (IVC collapsibility, cardiac chamber sizes)
  • Pericardial effusion/tamponade
  • Valvular abnormalities

This information directly determines next steps:

  • If hyperdynamic with small LV cavity → continue fluid resuscitation
  • If reduced LV function → add inotropes (dobutamine), limit fluids
  • If RV dysfunction → consider pulmonary embolism, adjust fluid strategy
  • If hypervolemic with poor function → diuretics, inotropes, consider mechanical support

Critical Pitfall

The greatest risk in this patient is administering additional large-volume fluid resuscitation without knowing cardiac function. With an S3 gallop, bilateral rales, and cardiomegaly, further aggressive fluid administration could precipitate acute pulmonary edema and respiratory failure. The 2025 guidelines specifically note that CCUS offers greater value "in septic patients where volume responsiveness is in question" and may offer less benefit in patients already hemodynamically optimized 1.

Ultrasound provides the diagnostic clarity needed to avoid this potentially fatal error and guides whether to give more fluid, add inotropes, or pursue alternative shock management strategies.

Related Questions

In a 27‑year‑old woman with type 2 diabetes, weight 86.6 kg, creatinine 0.40 mg/dL, GFR > 90 mL/min, currently taking neutral protamine Hagedorn (NPH) insulin 32 U at 8 am, dexamethasone 20 mg daily, with an insulin‑to‑carbohydrate ratio (ICR) of 1 U per 3 g carbohydrate and an insulin sensitivity factor (ISF) of 25 mg/dL per U, and blood glucose values of 207 mg/dL at 9 am, 229 mg/dL after a 90‑g carbohydrate meal, 373 mg/dL at 5 pm, 340 mg/dL at 9 pm, and 286 mg/dL at 2 am, what should the NPH basal insulin dose, ISF, and ICR be adjusted to?
Why did a 30‑year‑old male with chronic renal disease (weight 53 kg, creatinine 1.16 mg/dL, GFR 87 mL/min) who received tube feeding (224 g carbohydrate) from 8 pm to 8 am, was given NPH insulin 44 units at 8 pm, a 2‑unit correction dose at 10 am, and started on linezolid 600 mg at 8 pm and 8 am, develop severe hypoglycemia (blood glucose 34 mg/dL) at 11:30 am?
In a 39-year-old male with low muscle mass, normal serum creatinine (0.9 mg/dL) but elevated cystatin‑C (1.16 mg/L), no history of diabetes, hypertension, NSAID use, or autoimmune disease, normal urine and albumin‑to‑creatinine ratio, and renal ultrasound showing slight increased cortical echogenicity with normal corticomedullary differentiation and size, and a remote history of lithium use stopped two years ago, how should I proceed and what could be causing the elevated cystatin‑C?
In a 40‑year‑old man weighing 73 kg with type 1 diabetes, creatinine 1.24 mg/dL, eGFR 75 mL/min, currently on insulin glargine (Lantus) 14 U daily and fixed bolus doses of insulin aspart (Novolog) 18 U at breakfast, 14 U at lunch, and 10 U at dinner, who received dexamethasone 6 mg 24 hours ago and is now started on continuous insulin infusion (CII), what should his insulin glargine (Lantus) dose, insulin‑sensitivity factor (ISF), and insulin‑to‑carbohydrate ratio (ICR) be?
How should I manage a 25-year-old patient with type 2 diabetes, albumin‑creatinine ratio (ACR) 4 mg/g, HbA1c 10 %, experiencing diarrhea while on metformin and gliclazide 60 mg, who has restarted metformin 500 mg twice daily?
In a 67-year-old woman with community-acquired pneumonia admitted to the ICU for shock and acute hypoxemic respiratory failure, currently on volume assist-control ventilation (respiratory rate 14, tidal volume 6 mL/kg predicted body weight, FiO₂ 0.65, PEEP 5 cm H₂O) receiving norepinephrine 0.16 µg/kg/min, with hypotension, tachycardia, fever, and an arterial pressure tracing showing cyclic increasing and decreasing pressure peaks, what is the most appropriate immediate intervention: increase norepinephrine dose, give a diuretic challenge, administer a crystalloid bolus, or increase tidal volume to 8 mL/kg predicted body weight?
What is the differential diagnosis for small hyperpigmented maculae on the scrotum of a Black patient?
What is the ideal blood pressure target for patients with cardiovascular disease?
Can a patient with an absolute neutrophil count of 750 cells/µL and no signs of infection be discharged after receiving filgrastim (Neupogen)?
What are obstetric indicators, their objectives and implementation, including hospital and obstetric-specific indicators, how to conduct critical analyses, manage and plan their use, and what reference standards should be applied?
What is the condition called when a kidney stone causes infection and fever?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.